News

Disarming superbugs that can cause deadly infections is the focus of a powerful database now housed at The University of Queensland.

A new study has challenged the growing popular belief that the gut microbiome drives autism.

IMB researchers will tackle fundamental questions with $4.5 million of support from the NHMRC Idea Grants, including the researching devastating neural tube defects.

The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots, IMB researchers have confirmed.

A pathway discovered in cancer cells will inform future targeted therapies.

People with higher genetic risk of clinical depression are more likely to have physical symptoms such as chronic pain, fatigue and migraine.

Australia may soon have the jump on cane toads after a not-for-profit was granted an exclusive licence to market an IMB-designed bait for the invasive pests.

Drug discovery research at IMB has been given a $12.9 million boost of Australian Government funding, to push the boundaries for more targeted, efficient new medicines.

For every life-saving antibiotic introduced, bacteria have developed varying levels of resistance, replicating and adapting faster than human cells.

Researchers are daring to discover urgently needed new drugs and therapies from one of the most painful plants in Australia.

Chronic pain is a life-altering condition, but the answer to this devastating condition could come from an animal with a deadly sting.

It might be one of the most feared arachnids in the world, but research shows the deadly funnel web spider could make the difference between life and death for heart attack victims. 

Solar biotechnologies are being designed to expand Australian advanced manufacture, from next-generation COVID therapeutics through to renewable fuels. 

Associate Professor Markus Muttenthaler has been awarded an Australian Research Council (ARC) Future Fellowship.

Better medicines, food, nutraceuticals, nanomaterials and biofertilisers will flow from new Australian Government funding to bolster marine bioproduct innovation.

Chloe Yap, an IMB clinician-scientist has won the Judge’s Award at this year’s Queensland Women in STEM Awards.

A potentially life-saving treatment - Hi1a - for heart attack victims has been discovered from the venom of the Fraser Island funnel web spider.

IMB researchers are aiming to better understand how therapeutics can be delivered to target cells in the body.

The venom of a caterpillar, native to South East Queensland, shows promise for use in medicines and pest control.

Handling lethal cone snails and tackling deadly viruses and bacteria is all in a day’s work for four fearless IMB researchers working tirelessly to fast-track healthcare and medicines.